BOOM
Citations are updated once a week. Recently added citations may not appear.
| Context | Citation |
|---|---|
| yogurt - Ruminiclostridium |
📓
Chemoprevention of DMH-Induced Early Colon Carcinogenesis in Male BALB/c Mice by Administration of Lactobacillus Paracasei DTA81. Microorganisms (Microorganisms ) Vol: 8 Issue 12 Pages: Pub: 2020 Dec 14 Epub: 2020 Dec 14 Authors da Silva Duarte V , Dos Santos Cruz BC , Tarrah A , Sousa Dias R , de Paula Dias Moreira L , Lemos Junior WJF , Fidélis Silva LC , Rocha Santana G , Licursi de Oliveira L , Gouveia Peluzio MDC , Mantovani HC , Corich V , Giacomini A , de Paula SO , Html Article Publication |
| yogurt - Ruminiclostridium |
📓
Postbiotics Prepared Using Lactobacillus paracasei CCFM1224 Prevent Nonalcoholic Fatty Liver Disease by Modulating the Gut Microbiota and Liver Metabolism. International journal of molecular sciences (Int J Mol Sci ) Vol: 23 Issue 21 Pages: Pub: 2022 Nov 4 Epub: 2022 Nov 4 Authors Pan Z , Mao B , Zhang Q , Tang X , Yang B , Zhao J , Cui S , Zhang H , Html Article Publication |
| yogurt - Ruminiclostridium |
📓
Bifidobacterium bifidum Shows More Diversified Ways of Relieving Non-Alcoholic Fatty Liver Compared with Bifidobacterium adolescentis. Biomedicines (Biomedicines ) Vol: 10 Issue 1 Pages: Pub: 2021 Dec 31 Epub: 2021 Dec 31 Authors Wang L , Jiao T , Yu Q , Wang J , Wang L , Wang G , Zhang H , Zhao J , Chen W , Html Article Publication |
| yogurt - Ruminiclostridium |
👶
Effects of probiotic Enterococcus faecium NCIMB 11181 administration on swine fecal microbiota diversity and composition using barcoded pyrosequencing Animal Feed Science and Technology (Animal Feed Science and Technology ) Vol: 201 Issue Pages: 80-88 Pub: 2015 Mar Epub: Authors Edward Alain B.Pajarillo , Dae-Kyung Kang , Chan-Soo Park , Hyeun Bum Kim , Marilen P Balolong , Publication Publication |
BOOM
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
